• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Regulus Therapeutics Inc. (RGLS)

    -NasdaqGM
    5.94 Down 0.41(6.46%) Feb 5, 4:00PM EST
    |After Hours : 5.74 Down 0.20 (3.37%) Feb 5, 5:40PM EST
    Prev Close:6.35
    Open:6.47
    Bid:5.75 x 1000
    Ask:6.67 x 400
    1y Target Est:29.00
    Beta:2.04275
    Earnings Date:Mar 1 - Mar 2 (Est.)
    Day's Range:5.83 - 6.81
    52wk Range:5.23 - 21.22
    Volume:691,896
    Avg Vol (3m):449,889
    Market Cap:310.92M
    P/E (ttm):N/A
    EPS (ttm):-1.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RGLS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):23.54
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.19
    Quarterly EPS Est (Dec-15) :-0.25
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):-0.13

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback